Signal Says This Software Stock Could Soon Break Out
Shares of UiPath Inc (NYSE:PATH) are 1% higher trade at $13.53 this afternoon, extending its recent consolidation below the $14 level. PATH remains 17% lower year-to-date, pulling back nearly 30% from its early September highs. There may be a light at the end of the tunnel, however, as a historically bullish signal is now flashing.
Per Schaeffer's Senior Quantitative Analyst Rocky White, UiPath stock has traded within 0.75 times the 260-day moving average's 20-day average true range (ATR) after spending at least 80% of the previous two weeks and 80% of the prior 42 trading sessions above the trendline.
This setup has appeared two times over the last 10 years, after which the stock was higher one month later both times, averaging a 7.8% gain. From its current perch, a move of this magnitude would put PATH back above the $14 threshold.
Options traders have been pessimistic at best. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), UiPath stock's 50-day put/call volume ratio ranks higher than 86% of annual readings. Echoing this, the stock's Schaeffer's put/call open interest ratio (SOIR) sits above 91% of readings from the past 12 months.
Shorts have been retreating, with short interest falling 14.9% during the past two reporting periods. At the stock's average pace of daily trading, it would take short sellers less than two days to buy back their bearish bets.
There is plenty of room for bull notes, too. Currently 18 of the 20 brokerages in coverage sport a "hold" or "sell" recommendation. Should this bearish sentiment begin to unwind, it could trigger a fresh round of upgrades for PATH.
Lastly, options are affordably priced as well. Specifically, the software stock's Schaeffer's Volatility Index (SVI) of 57% stands in the 14th percentile of its annual range.
Comments 0
Leave a Reply
Your email address will not be published. Required fields are marked *
Business & Finance
Explore All
AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why.
Behind the Ticker: Crossmark's Values-Based ETFs
2 hours ago
Signal Says This Software Stock Could Soon Break Out
3 hours ago
Loren Finegold, Ed Comber Join Vinson & Elkins NY Practice, Finance & Infrastructure Growth
3 hours agoHalliburton Signs Deals to Expand Venezuela Energy Presence
3 hours agoWhats New
View All
SEE IT: Chinese nationals intercepted in ‘extremely dangerous’ infiltration attempt near Florida coast
NASA Astronaut Reid Wiseman Attends Ravens vs. Saints Game
AI, Tariffs, Rare Minerals: What to Expect From Trump’s Upcoming Summit With Xi Jinping
Resident Evil Director Reacts To People Who Didn’t Like The Controversial Ending, Says It Was Almost Completely Different
Kairos Power gets up to $100M from Samsung group to build nuclear reactor for Google
WGA Settles Antitrust Lawsuit With Paramount Over Warner Bros. Discovery Merger
Jupiter & Mars Definitive Edition Launch Trailer – Nintendo Switch
David Ellison Says Paramount Hopes to Close Warner Bros. Deal in ‘Approximately Two Weeks’ in Staff Memo
Blue state gov ignites online firestorm with plan to send gov't into homes of newborn babies: 'Lunatic libs'